Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGS - Nasdaq Real Time Price USD

DexCom, Inc. (DXCM)

Compare
Time to buy DXCM?
67.32
-0.97
(-1.42%)
At close: 4:00:01 PM EDT
67.32
0.00
(0.00%)
After hours: 4:15:06 PM EDT
Time to buy DXCM?
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
4,033,000
4,033,000
3,622,300
2,909,800
2,448,500
Cost of Revenue
1,594,800
1,594,800
1,333,400
1,026,700
768,000
Gross Profit
2,438,200
2,438,200
2,288,900
1,883,100
1,680,500
Operating Expense
1,838,200
1,838,200
1,691,200
1,491,900
1,414,700
Operating Income
600,000
600,000
597,700
391,200
265,800
Net Non Operating Interest Income Expense
115,200
115,200
114,700
5,200
-17,100
Other Income Expense
-6,200
-6,200
-2,000
-5,600
8,100
Pretax Income
709,000
709,000
710,400
390,800
256,800
Tax Provision
132,800
132,800
168,900
49,600
39,900
Net Income Common Stockholders
576,200
576,200
541,500
341,200
216,900
Average Dilution Earnings
11,500
11,500
12,600
11,000
11,400
Diluted NI Available to Com Stockholders
587,700
587,700
554,100
352,200
228,300
Basic EPS
1.46
1.46
1.40
0.88
0.40
Diluted EPS
1.42
1.42
1.30
0.82
0.39
Basic Average Shares
393,600
393,600
386,000
389,400
386,800
Diluted Average Shares
412,700
412,700
425,500
427,500
400,400
Total Operating Income as Reported
600,000
600,000
597,700
391,200
265,800
Total Expenses
3,433,000
3,433,000
3,024,600
2,518,600
2,182,700
Net Income from Continuing & Discontinued Operation
576,200
576,200
541,500
341,200
216,900
Normalized Income
576,200
576,200
541,500
341,200
216,960.10
Interest Income
134,200
134,200
135,000
23,800
1,700
Interest Expense
19,000
19,000
20,300
18,600
18,800
Net Interest Income
115,200
115,200
114,700
5,200
-17,100
EBIT
728,000
728,000
730,700
409,400
275,600
EBITDA
945,700
945,700
916,700
565,300
377,600
Reconciled Cost of Revenue
1,594,800
1,594,800
1,333,400
1,026,700
768,000
Reconciled Depreciation
217,700
217,700
186,000
155,900
102,000
Net Income from Continuing Operation Net Minority Interest
576,200
576,200
541,500
341,200
216,900
Total Unusual Items Excluding Goodwill
--
--
--
--
-100
Total Unusual Items
--
--
--
--
-100
Normalized EBITDA
945,700
945,700
916,700
565,300
377,700
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
--
--
--
--
-39.90
12/31/2021 - 4/14/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SENS Senseonics Holdings, Inc.
0.6649
+1.34%
 
PODD Insulet Corporation
263.18
+0.22%
 
EW Edwards Lifesciences Corporation
71.87
-0.84%
 
TNDM Tandem Diabetes Care, Inc.
18.73
-2.24%
 
ABT Abbott Laboratories
131.69
-0.72%
 
MDT Medtronic plc
88.49
-1.52%
 
BSX Boston Scientific Corporation
101.24
+0.36%
 
SYK Stryker Corporation
373.30
+0.28%
 
BBNX Beta Bionics, Inc.
11.24
-8.17%
 
MASI Masimo Corporation
167.61
+0.61%